505(b)(2) means A new drug application that contains full reports of investigations of safety and effectiveness but where at least some of the information required for approval comes from studies not conducted by or for the applicant and for which the applicant has not obtained a right of reference. in FDA
Similar to 505(b)(2)
ACUS - Administrative Conference of the United StatesACWA - Administrative Careers With America
AD - Action Due
ad lib - as much as needed
ADA - American Dental Association
ADA - Americans with Disabilities Act of 1990
ADAA - Animal Drug Availability Act of 1996
View all in FDA